Chitneni SK - Search Results

1

Chitneni SK, Palmer GM, Zalutsky MR, Dewhirst MW. Chitneni SK, et al. J Nucl Med. 2011 Feb;52(2):165-8. doi: 10.2967/jnumed.110.075663. Epub 2011 Jan 13. J Nucl Med. 2011. PMID: 21233176 Free PMC article. Review.

2

A simplified synthesis of the hypoxia imaging agent 2-(2-Nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-[(18)F]pentafluoropropyl)-acetamide ([18F]EF5).

Chitneni SK, Bida GT, Dewhirst MW, Zalutsky MR. Chitneni SK, et al. Nucl Med Biol. 2012 Oct;39(7):1012-8. doi: 10.1016/j.nucmedbio.2012.05.006. Epub 2012 Jun 22. Nucl Med Biol. 2012. PMID: 22727821 Free PMC article.

3

18F-EF5 PET imaging as an early response biomarker for the hypoxia-activated prodrug SN30000 combined with radiation treatment in a non-small cell lung cancer xenograft model.

Chitneni SK, Bida GT, Yuan H, Palmer GM, Hay MP, Melcher T, Wilson WR, Zalutsky MR, Dewhirst MW. Chitneni SK, et al. J Nucl Med. 2013 Aug;54(8):1339-46. doi: 10.2967/jnumed.112.116293. Epub 2013 Jun 5. J Nucl Med. 2013. PMID: 23740105 Free PMC article.

4

Comparison of the Hypoxia PET Tracer (18)F-EF5 to Immunohistochemical Marker EF5 in 3 Different Human Tumor Xenograft Models.

Chitneni SK, Bida GT, Zalutsky MR, Dewhirst MW. Chitneni SK, et al. J Nucl Med. 2014 Jul;55(7):1192-7. doi: 10.2967/jnumed.114.137448. Epub 2014 May 22. J Nucl Med. 2014. PMID: 24854792 Free PMC article.

5

Reply: Pharmacokinetic and Pharmacodynamic Modifiers of EF5 Uptake and Binding.

Chitneni SK, Bida GT, Zalutsky MR, Dewhirst MW. Chitneni SK, et al. J Nucl Med. 2015 Apr;56(4):653-4. doi: 10.2967/jnumed.115.154054. Epub 2015 Mar 5. J Nucl Med. 2015. PMID: 25745087 Free article. No abstract available.

6

D-Amino acid peptide residualizing agents bearing N-hydroxysuccinimido- and maleimido-functional groups and their application for trastuzumab radioiodination.

Pruszynski M, Koumarianou E, Vaidyanathan G, Chitneni S, Zalutsky MR. Pruszynski M, et al. Nucl Med Biol. 2015 Jan;42(1):19-27. doi: 10.1016/j.nucmedbio.2014.08.007. Epub 2014 Aug 13. Nucl Med Biol. 2015. PMID: 25240914 Free PMC article.

7

Fluorine-18 labeling of an anti-HER2 VHH using a residualizing prosthetic group via a strain-promoted click reaction: Chemistry and preliminary evaluation.

Zhou Z, Chitneni SK, Devoogdt N, Zalutsky MR, Vaidyanathan G. Zhou Z, et al. Among authors: chitneni sk. Bioorg Med Chem. 2018 May 1;26(8):1939-1949. doi: 10.1016/j.bmc.2018.02.040. Epub 2018 Mar 15. Bioorg Med Chem. 2018. PMID: 29534937 Free PMC article.

8

Fluorine-18 Labeling of the MDM2 Inhibitor RG7388 for PET Imaging: Chemistry and Preliminary Evaluation.

Zhou Z, Zalutsky MR, Chitneni SK. Zhou Z, et al. Among authors: chitneni sk. Mol Pharm. 2021 Oct 4;18(10):3871-3881. doi: 10.1021/acs.molpharmaceut.1c00531. Epub 2021 Sep 15. Mol Pharm. 2021. PMID: 34523337 Free PMC article.

9

Synthesis and Evaluation of a ¹⁸F-Labeled Triazinediamine Analogue for Imaging Mutant IDH1 Expression in Gliomas by PET.

Chitneni SK, Yan H, Zalutsky MR. Chitneni SK, et al. ACS Med Chem Lett. 2018 May 1;9(7):606-611. doi: 10.1021/acsmedchemlett.7b00478. eCollection 2018 Jul 12. ACS Med Chem Lett. 2018. PMID: 30034587 Free PMC article.

10

Radiolabeled inhibitors as probes for imaging mutant IDH1 expression in gliomas: Synthesis and preliminary evaluation of labeled butyl-phenyl sulfonamide analogs.

Chitneni SK, Reitman ZJ, Gooden DM, Yan H, Zalutsky MR. Chitneni SK, et al. Eur J Med Chem. 2016 Aug 25;119:218-30. doi: 10.1016/j.ejmech.2016.04.066. Epub 2016 Apr 28. Eur J Med Chem. 2016. PMID: 27163884 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters